UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
-------------
Sano Corporation
-----------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------
(Title of Class of Securities)
80105E105
-----------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this
statement /X/. (A fee is not required only if the filing
person: (1) has a previous statement on file reporting bene-
ficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amend-
ment subsequent thereto reporting beneficial ownership of
five percent or less of such class.) (See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the dis-
closures provided in a prior page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or other-
wise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act
(however, see the Notes).
<PAGE>
<PAGE>
CUSIP No. 80105E105 13G
- -----------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S.
Identification Nos. of Above Persons
Pharmaceutical Resources, Inc.
- ------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- ------------------------------------------------------------
(3) SEC Use Only
- ------------------------------------------------------------
(4) Citizenship or Place of Organization
New Jersey
- ------------------------------------------------------------
Number of Shares (5) Sole Voting
Beneficially Power 513,888
Owned by ------------------------------
Each Reporting (6) Shared Voting
Person With Power None
------------------------------
(7) Shared Dispositive
Power 513,888
------------------------------
(8) Shared Dispositive
Power None
- ------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting
Person
513,888
- ------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares*
- ------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
6.0%
- ------------------------------------------------------------
(12) Type of Reporting Person*
CO
- ------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Item 1.
(a) NAME OF ISSUER: Sano Corporation
(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
3250 Commerce Parkway, Miramar, Florida 33025
Item 2.
(a)-(c) NAME OF PERSON FILING: ADDRESS OF PRINCIPAL
BUSINESS OFFICE; AND PLACE OF ORGANIZATION: This
statement is filed on behalf of Pharmaceutical
Resources, Inc., a New Jersey corporation (the
"Company"). The principal business office of the
Company is One Ram Ridge Road, Spring Valley, New
York 10977.
2(b) TITLE OF CLASS OF SECURITIES: Common Stock
2(c) CUSIP NUMBER: 80105E105
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-
1(b), OR 13-2(b), CHECK WHETHER THE PERSON FILING
IS A:
(a) ( ) Broker or Dealer registered under section 15 of
the Act
(b) ( ) Bank as defined in section 3(a) (6) of the Act
(c) ( ) Insurance Company as defined in Section
(d) ( ) Investment Company registered under section 8 of
the Investment Company Act
(e) ( ) Investment Adviser registered under section 203 of
the Investment Advisers Act of 1940
(f) ( ) Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee
Retirement Income Security Act of 1974 or
Endowment Fund
(g) ( ) Parent Holding Company, in accordance with
Section 240.13d-1 (b) (ii) (G)
(h) ( ) Group, in accordance with Section 240.13d-1 (b) (1) (ii)
(H)
Item 4. OWNERSHIP:
(a) AMOUNT BENEFICIALLY OWNED: 513,888 shares of Common
Stock.
(b) PERCENT OF CLASS: 6.0%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) sole power to vote or to direct the vote: 513,888.
(ii) shared power to vote or to direct the vote: 0.
(iii) sole power to dispose or to direct the disposition
of: 513,888.
(iv) shared power to dispose or to direct the disposition
of: 0
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
If this statement is being filed to report the
fact that as of the date hereof the reporting person has
ceased to be the beneficial owner of more than five percent
of the class of securities, check the following ____.
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON:
Not Applicable.
Item 7. IDENTIFICATION AND CLASSIFICATION OF THE
SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING
REPORTED ON BY THE PARENT HOLDING COMPANY:
Not Applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF
THE GROUP:
Not Applicable.
Item 9. NOTICES OF DISSOLUTION OF GROUP:
Not Applicable.
Item 10. CERTIFICATION:
By signing below Pharmaceutical Resources, Inc.
certifies that, to the best of its knowledge and belief, the
securities referred to above were acquired in the ordinary
course of business and were acquired for the purpose of and do
not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of its
knowledge and belief, the undersigned certifies that the
information set forth in this statement is true, complete
and correct.
Date: February 1, 1996
PHARMACEUTICAL RESOURCES, INC.
By:/s/ Robert I. Edinger
----------------------------
Robert I. Edinger
Executive Vice President
and Secretary
